TGFβ1-modified MSC-derived exosome attenuates osteoarthritis by inhibiting PDGF-BB secretion and H-type vessel activity in the subchondral bone
Authors:
- 4 August 2022
- journal article
- research article
- Published by Elsevier in Acta Histochemica
- Vol. 124 (7) , 151933
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Subchondral bone in osteoarthritis: insight into risk factors and microstructural changesArthritis Research & Therapy, 2013
- Interplay between Cartilage and Subchondral Bone Contributing to Pathogenesis of OsteoarthritisInternational Journal of Molecular Sciences, 2013
- TGF-β and osteoarthritis—the good and the badNature Medicine, 2013
- Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritisNature Medicine, 2013
- Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trialAnnals of the Rheumatic Diseases, 2012
- Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cellsNature Medicine, 2012
- The bone–cartilage unit in osteoarthritisNature Reviews Rheumatology, 2010
- TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formationNature Medicine, 2009
- Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritisAnnals of the Rheumatic Diseases, 2007
- Osteoarthritis of the KneeNew England Journal of Medicine, 2006